Portolan Capital Management’s BM Technologies, Inc. Warrants, each warrant exercisable for one share of Common Stock at an exercise price of $11.50 BMTX.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-264,025
Closed -$494K 177
2021
Q4
$494K Sell
264,025
-10,214
-4% -$20.5K 0.03% 128
2021
Q3
$409K Buy
274,239
+169
+0.1% +$313 0.03% 131
2021
Q2
$704K Sell
274,070
-299,035
-52% -$655K 0.05% 124
2021
Q1
$1.15M Buy
+573,105
New +$1.59M 0.09% 136

Other funds holding BMTX.WS

Portolan Capital Management's BMTX.WS Position: Q1 2022 in Review

Portolan Capital Management sold out of BM Technologies, Inc. Warrants, each warrant exercisable for one share of Common Stock at an exercise price of $11.50 (BMTX.WS) in Q1 2022, closing a stake of 264,025 shares — an estimated $494K sold.

Portolan Capital Management first reported a position in BMTX.WS in Q1 2021 and held it in 4 quarters. The position peaked at $1.15M in Q1 2021. 13 funds tracked by Wall St. Rank hold BMTX.WS as of Q1 2022.

  • Portolan Capital Management reported no remaining BM Technologies, Inc. Warrants, each warrant exercisable for one share of Common Stock at an exercise price of $11.50 position as of Q1 2022 after selling out during the quarter.
  • Portolan Capital Management sold 264,025 BM Technologies, Inc. Warrants, each warrant exercisable for one share of Common Stock at an exercise price of $11.50 shares in Q1 2022, an estimated $494K.
  • Portolan Capital Management first reported a position in BM Technologies, Inc. Warrants, each warrant exercisable for one share of Common Stock at an exercise price of $11.50 in Q1 2021 and held it in 4 quarters.
  • Portolan Capital Management's BM Technologies, Inc. Warrants, each warrant exercisable for one share of Common Stock at an exercise price of $11.50 position peaked at $1.15M in Q1 2021.
  • 13 funds tracked by Wall St. Rank held BM Technologies, Inc. Warrants, each warrant exercisable for one share of Common Stock at an exercise price of $11.50 as of Q1 2022.

Based on Portolan Capital Management's 13F filing for Q1 2022, filed 16 May 2022.